These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8399995

  • 1. HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimetics.
    Ghosh AK, McKee SP, Sanders WM, Darke PL, Zugay JA, Emini EA, Schleif WA, Quintero JC, Huff JR, Anderson PS.
    Drug Des Discov; 1993; 10(1):77-88. PubMed ID: 8399995
    [Abstract] [Full Text] [Related]

  • 2. Specificity mapping of HIV-1 protease by reduced bond inhibitors.
    Majer P, Urban J, Gregorová E, Konvalinka J, Novek P, Stehlíková J, Andreánsky M, Sedlácek J, Strop P.
    Arch Biochem Biophys; 1993 Jul; 304(1):1-8. PubMed ID: 8323274
    [Abstract] [Full Text] [Related]

  • 3. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
    Tamamura H, Koh Y, Ueda S, Sasaki Y, Yamasaki T, Aoki M, Maeda K, Watai Y, Arikuni H, Otaka A, Mitsuya H, Fujii N.
    J Med Chem; 2003 Apr 24; 46(9):1764-8. PubMed ID: 12699395
    [Abstract] [Full Text] [Related]

  • 4. Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.
    Fässler A, Bold G, Capraro HG, Cozens R, Mestan J, Poncioni B, Rösel J, Tintelnot-Blomley M, Lang M.
    J Med Chem; 1996 Aug 02; 39(16):3203-16. PubMed ID: 8759643
    [Abstract] [Full Text] [Related]

  • 5. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
    Ghosh AK, Kincaid JF, Walters DE, Chen Y, Chaudhuri NC, Thompson WJ, Culberson C, Fitzgerald PM, Lee HY, McKee SP, Munson PM, Duong TT, Darke PL, Zugay JA, Schleif WA, Axel MG, Lin J, Huff JR.
    J Med Chem; 1996 Aug 16; 39(17):3278-90. PubMed ID: 8765511
    [Abstract] [Full Text] [Related]

  • 6. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
    Beaulieu PL, Wernic D, Abraham A, Anderson PC, Bogri T, Bousquet Y, Croteau G, Guse I, Lamarre D, Liard F, Paris W, Thibeault D, Pav S, Tong L.
    J Med Chem; 1997 Jul 04; 40(14):2164-76. PubMed ID: 9216835
    [Abstract] [Full Text] [Related]

  • 7. Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.
    Thaisrivongs S, Janakiraman MN, Chong KT, Tomich PK, Dolak LA, Turner SR, Strohbach JW, Lynn JC, Horng MM, Hinshaw RR, Watenpaugh KD.
    J Med Chem; 1996 Jun 07; 39(12):2400-10. PubMed ID: 8691434
    [Abstract] [Full Text] [Related]

  • 8. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.
    Bouzide A, Sauvé G, Yelle J.
    Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1509-13. PubMed ID: 15713418
    [Abstract] [Full Text] [Related]

  • 9. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK, Swanson LM, Cho H, Leshchenko S, Hussain KA, Kay S, Walters DE, Koh Y, Mitsuya H.
    J Med Chem; 2005 May 19; 48(10):3576-85. PubMed ID: 15887965
    [Abstract] [Full Text] [Related]

  • 10. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands.
    Jungheim LN, Shepherd TA, Baxter AJ, Burgess J, Hatch SD, Lubbehusen P, Wiskerchen M, Muesing MA.
    J Med Chem; 1996 Jan 05; 39(1):96-108. PubMed ID: 8568831
    [Abstract] [Full Text] [Related]

  • 11. Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.
    Hidaka K, Kimura T, Abdel-Rahman HM, Nguyen JT, McDaniel KF, Kohlbrenner WE, Molla A, Adachi M, Tamada T, Kuroki R, Katsuki N, Tanaka Y, Matsumoto H, Wang J, Hayashi Y, Kempf DJ, Kiso Y.
    J Med Chem; 2009 Dec 10; 52(23):7604-17. PubMed ID: 19954246
    [Abstract] [Full Text] [Related]

  • 12. Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: secondary amide series.
    Reich SH, Melnick M, Pino MJ, Fuhry MA, Trippe AJ, Appelt K, Davies JF, Wu BW, Musick L.
    J Med Chem; 1996 Jul 05; 39(14):2781-94. PubMed ID: 8709109
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors.
    Narendra Babu SN, Rangappa KS.
    Bioorg Med Chem; 2008 Jan 15; 16(2):874-80. PubMed ID: 17981043
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of a new hydroxyethylene dipeptide isostere Phe psi [CH2CH (OH)]Phe as HIV-1 protease inhibitor.
    Chen HG, Sawyer TK, Wuts PG.
    Zhongguo Yao Li Xue Bao; 1994 Jan 15; 15(1):33-5. PubMed ID: 8010081
    [Abstract] [Full Text] [Related]

  • 15. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.
    Thaisrivongs S, Romero DL, Tommasi RA, Janakiraman MN, Strohbach JW, Turner SR, Biles C, Morge RR, Johnson PD, Aristoff PA, Tomich PK, Lynn JC, Horng MM, Chong KT, Hinshaw RR, Howe WJ, Finzel BC, Watenpaugh KD.
    J Med Chem; 1996 Nov 08; 39(23):4630-42. PubMed ID: 8917652
    [Abstract] [Full Text] [Related]

  • 16. Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold.
    Alterman M, Björsne M, Mühlman A, Classon B, Kvarnström I, Danielson H, Markgren PO, Nillroth U, Unge T, Hallberg A, Samuelsson B.
    J Med Chem; 1998 Sep 24; 41(20):3782-92. PubMed ID: 9748353
    [Abstract] [Full Text] [Related]

  • 17. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y, Matsumoto H, Mizumoto S, Kimura T, Fujiwara Y, Akaji K.
    Biopolymers; 1999 Sep 24; 51(1):59-68. PubMed ID: 10380353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands.
    Ghosh AK, Schiltz G, Perali RS, Leshchenko S, Kay S, Walters DE, Koh Y, Maeda K, Mitsuya H.
    Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1869-73. PubMed ID: 16480871
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
    Mimoto T, Kato R, Takaku H, Nojima S, Terashima K, Misawa S, Fukazawa T, Ueno T, Sato H, Shintani M, Kiso Y, Hayashi H.
    J Med Chem; 1999 May 20; 42(10):1789-802. PubMed ID: 10346931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.